-Top Gainer - DD// -

[LMLYP]

Page three goes in to more detail, but every letter addresses their dependence on and relationship with a certified lab. I more than acknowledge this risk, reflecting on whether this has kept management up at night for two decades. It won't stop me from recommending or bidding to get back shares.

https://s3.amazonaws.com/com-pharmcheck-cdn/document-uploads/2019-Letter-to-Stockholders.pdf?mtime=20200429124248